Moderna Inc. revealed on Friday that its total revenue for the second quarter of fiscal 2026 landed at $145 million, up 2% compared to the same period a year ago and slightly below market estimates.
In the reported period, the biotechnology giant reported a $782 million net loss, compared to the $825 million net loss recorded in the second quarter of 2025. Its diluted loss per share came in at $1.97, improving from the $2.13 loss per share observed a year prior.
"The second quarter marked another period of strong execution for Moderna as we advanced our pipeline and strengthened our financial profile with an improved 2026 operating expense outlook," CEO Stephane Bancel noted.
Moderna's stock dropped 7.61% in premarket following the release of the report.
https://breakingthenews.net/Article/Moderna's-Q2-revenue-up-2-to-dollar145-million/66825384
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.